Fig. 6From: Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapyIn vitro biocompatibility and in vivo biosafety assay. A H&E staining of the major organ tissues. B Routine blood tests. C Blood biochemistry analysis. All of the abovementioned examinations were performed after an intravenous injection with PBS and DNMF/PLGA NPs (1, 7, and 14 days). Data are presented as the mean ± SDBack to article page